| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.007 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |